Short Interest in NLS Pharmaceutics Ltd. (NASDAQ:NLSP) Declines By 28.2%

NLS Pharmaceutics Ltd. (NASDAQ:NLSP) was the target of a significant drop in short interest in the month of March. As of March 15th, there was short interest totalling 41,800 shares, a drop of 28.2% from the February 28th total of 58,200 shares. Based on an average daily volume of 2,580,000 shares, the days-to-cover ratio is presently 0.0 days. Approximately 2.7% of the company’s stock are sold short.

NLS Pharmaceutics Stock Performance

Shares of NASDAQ:NLSP traded down $0.23 during trading on Friday, hitting $1.30. The company’s stock had a trading volume of 44,239 shares, compared to its average volume of 837,966. NLS Pharmaceutics has a fifty-two week low of $1.30 and a fifty-two week high of $18.39. The business has a 50 day moving average price of $1.85 and a two-hundred day moving average price of $2.53.

NLS Pharmaceutics Company Profile

NLS Pharmaceutics AG, a clinical-stage biopharmaceutical company, engages in the discovery and development of therapies for patients with rare and complex central nervous system disorders. The company is focusing on the development of treatments for narcolepsy, idiopathic hypersomnia, and other rare sleep disorders, as well as neurodevelopmental disorders, such as attention deficit hyperactivity disorder (ADHD).